While resveratrol downregulated the gene expression of PPAR-γ and SREBP-1c in the NAFLD rat model [66], the current reviewed RCTs did not show consistent decrease in lipid profile. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.